The Latest
-
Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs
The lawsuit follows a cease-and-desist request and argues Lilly is using “deceptive” ads to claim its GLP-1 products are broadly superior to Novo’s medicines. Lilly countered that its campaign is “truthful.”
-
Sponsored by Cedar Gate Technologies, an IQVIA business
3 essential capabilities to scale impact and collaboration in VBC
Discover the critical tools you need to succeed in a collaborative, tech-enabled VBC future.
-
Clinic and physician practice bankruptcies spike in 2026 so far
The bankruptcies come as the healthcare sector faces looming financial pressures, including cuts to Medicaid, according to the report by Gibbins Advisors.
-
Clover Health hit with data breach
The insurer, which disclosed the breach in a securities filing late last week, doesn’t yet know what type of data was exposed or how many people may have been impacted.
-
Doc pay, price transparency on Congress’ healthcare agenda
Lawmakers introduced or advanced a raft of health legislation last week in advance of the midterm elections.
-
Employers push health savings plans, nutritional counseling to avoid GLP-1 coverage for weight loss
Cost remains a major factor for employers as the popular drugs represented 11.4% of corporations’ annual claims in 2025.
-
340B spending ballooned to $100B in 2025, federal data shows
It's the latest evidence of rising spending in the drug discount program as regulators attempt to tamp down on growth in 340B.
-
Senate Republicans kill bid to end Medicare prior authorization pilot
The Senate voted along party lines Thursday to defeat Democrats’ attempt to end WISeR, which some lawmakers argue is delaying care for seniors.
-
Judge stays Trump administration policies set to shrink ACA marketplaces
On Thursday, a federal judge pressed pause on the CMS’ expansion of bare-bones catastrophic plans and other changes finalized in a rule this spring, saying they were likely to raise costs and hurt access.
-
UnitedHealth raises 2026 guidance again as cost controls pay off in Q2
UnitedHealth’s profit spiked to $5.5 billion in the second quarter thanks to notable earnings recovery in its insurance and value-based care delivery businesses. The healthcare juggernaut delivered for investors, analysts said.
-
Large funding rounds help boost digital health investment in H1
Venture capital funding deals worth $100 million or more made up nearly half of all money invested so far this year, according to Rock Health.
-
Elevance shuts down D.C. Medicaid business, eyes additional exits after passable Q2
Elevance will leave D.C. this summer and is considering other markets to depart, executives said. The company outperformed Wall Street expectations in the second quarter — but not by much, and its stock fell accordingly.
Updated July 17, 2026 -
Healthcare sector faces persistent supply-chain security, identity management challenges
A new report says doctors and nurses should train for cyberattacks the way firefighters train for major blazes — even if they expect them to be rare.
-
Judge tosses another No Surprises lawsuit against HaloMD
It's the third recent legal victory in No Surprises lawsuits for billings intermediary HaloMD, which has also had suits dismissed in California and Texas.
-
Doctor pay to drop in 2027 under proposed Medicare pay rule
Physician groups said the sweeping rule is a double-edged sword, given it includes an unwelcome fee cut but positive changes to Medicare’s value-based and quality payment programs.
-
CVS Caremark reaches settlement with FTC over insulin suit
Terms of the deal announced Tuesday are very similar to those the FTC reached with Express Scripts earlier this year, including requiring the PBM to stop preferring higher cost versions of drugs on standard formularies.
-
Providence names new chief supply chain officer
Amanda Chawla comes to the Washington-based nonprofit giant from Stanford Medicine. Providence is hoping her appointment will bolster its supply chain capabilities during a time of elevated spend.
-
Whoop tests wearable platform in joint replacement recovery
The program, a partnership with Kinomatic, will use biometric data and care coordination between visits to support recovery after surgery.
-
HCA cuts 2026 earnings forecast on insurance coverage losses
Payer mix changes, mostly from people dropping out of Affordable Care Act plans, caused HCA to lose $400 million in the second quarter — much more than the company (or its investors) had expected.
-
‘The system is undeniably broken’: More insurers sue CMS over Medicare Advantage stars
SCAN Health Plan and Alignment Healthcare both filed lawsuits against the CMS last week after regulators refused to recalculate industry-wide MA scores using the same methodology as for Clover Health.
-
HHS watchdog says it’s targeting Medicaid, Medicare Advantage fraud
The HHS Office of Inspector General removed over 1,200 people and entities from federal programs between October and March as the Trump administration ratchets up oversight into healthcare fraud.
-
Hospital M&A sustains momentum in Q2: report
Hospitals and health systems recorded 18 transactions in the second quarter after a lull in dealmaking early last year as providers partner up in a bid to bolster their finances.
-
Soon-to-expire ACO REACH generates more savings for Medicare
The model, which is set to sunset at the end of this year, generated $988 million in savings for Medicare in 2024, according to new CMS data. That’s up from almost $695 million in savings from the year prior.
-
Retrieved from Memorial Hermann on July 10, 2026
Memorial Hermann exits commercial insurance business
The Houston-based nonprofit is the latest integrated system to throw in the towel on some of its insurance plans amid a tough cost and policy environment.
-
Tracker
Tracking healthcare data breaches
A data breach at a New Jersey lab testing provider may have exposed the information of more than 540,000 people.
Updated July 13, 2026 -
CVS CEO says Aetna has a handle on medical costs in advance of Q2 earnings
David Joyner’s assurances, which come about a month before CVS is scheduled to report its second quarter results, will likely be welcomed by investors wary after a difficult few years for insurers.